DarioHealth Corp. Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
DarioHealth Corp. (DRIO) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price of $0.00 per share for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-10.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice · last filed 2025-03-10
- DarioHealth Corp. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2021-03-31 was $5.96.
- DarioHealth Corp. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2019-03-31 was $0.00.
- DarioHealth Corp. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2015-03-31 was $0.01.
- DarioHealth Corp. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2024 was $0.00.
- DarioHealth Corp. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2023 was $0.00.
- DarioHealth Corp. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- DarioHealth Corp. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2021 was $6.00.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-10 | |||
| 2023-12-31 | $0.00 10-K · filed 2024-03-28 | |||
| 2022-12-31 | $0.00 10-K · filed 2023-03-09 | |||
| 2021-12-31 | $6.00 10-K · filed 2022-03-22 | |||
| 2021-09-30 | $6.32 10-Q · filed 2021-11-15 | |||
| 2021-06-30 | $6.32 10-Q · filed 2021-08-16 | |||
| 2021-03-31 | $5.96 10-Q · filed 2021-05-17 | |||
| 2020-12-31 | $0.00 10-K · filed 2021-03-09 | |||
| 2020-09-30 | $0.00 10-Q · filed 2020-11-12 | |||
| 2020-06-30 | $0.00 10-Q · filed 2020-08-12 | |||
| 2019-12-31 | $0.00 10-K · filed 2020-03-17 | |||
| 2019-09-30 | $0.00 10-Q · filed 2019-10-28 | |||
| 2019-06-30 | $0.00 10-Q · filed 2019-08-13 | |||
| 2019-03-31 | $0.00 10-Q · filed 2019-05-13 | |||
| 2018-12-31 | $0.00 10-K · filed 2019-03-25 | |||
| 2017-12-31 | $0.00 10-K · filed 2018-03-19 | |||
| 2016-12-31 | $0.00 10-K · filed 2017-03-22 | |||
| 2015-12-31 | $0.01 10-K · filed 2016-02-08 | |||
| 2015-06-30 | $0.01 10-Q · filed 2015-08-12 | |||
| 2015-03-31 | $0.01 10-Q · filed 2015-05-14 | |||
| 2014-12-31 | $0.09 10-K · filed 2015-03-24 | |||
| 2013-12-31 | $0.00 10-K · filed 2014-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |